Close
  Indian J Med Microbiol
 

Figure 3: The cytotoxicity of Moringa oleifera leaf ethyl acetate fraction treatment in diabetic human dermal fibroblast cells was assessed. Cells were treated with various concentrations of isolated fractions (15.62, 31.25, 62.5, 125, 250, and 500 μg/mL) for 24 h. After the incubation period, the viability of fraction-treated cells was evaluated by 3-(4,5-dimethythiazol- 2-yl)-2,5-diphenyl tetrazolium bromide assay. Values are presented as the mean percentage ± standard deviation of three replicates. ***P < 0.001 versus control group

Figure 3: The cytotoxicity of <i>Moringa oleifera</i> leaf ethyl acetate fraction treatment in diabetic human dermal fibroblast cells was assessed. Cells were treated with various concentrations of isolated fractions (15.62, 31.25, 62.5, 125, 250, and 500 μg/mL) for 24 h. After the incubation period, the viability of fraction-treated cells was evaluated by 3-(4,5-dimethythiazol- 2-yl)-2,5-diphenyl tetrazolium bromide assay. Values are presented as the mean percentage ± standard deviation of three replicates. ***<i>P</i> < 0.001 versus control group